670 related articles for article (PubMed ID: 33341248)
21. Next generation human skin constructs as advanced tools for drug development.
Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Development in Organ-On-A-Chip Technology.
Joseph X; Akhil V; Arathi A; Mohanan PV
J Pharm Sci; 2022 Jan; 111(1):18-31. PubMed ID: 34324944
[TBL] [Abstract][Full Text] [Related]
23. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.
Marx U; Andersson TB; Bahinski A; Beilmann M; Beken S; Cassee FR; Cirit M; Daneshian M; Fitzpatrick S; Frey O; Gaertner C; Giese C; Griffith L; Hartung T; Heringa MB; Hoeng J; de Jong WH; Kojima H; Kuehnl J; Leist M; Luch A; Maschmeyer I; Sakharov D; Sips AJ; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tralau T; Tsyb S; van de Stolpe A; Vandebriel R; Vulto P; Wang J; Wiest J; Rodenburg M; Roth A
ALTEX; 2016; 33(3):272-321. PubMed ID: 27180100
[TBL] [Abstract][Full Text] [Related]
24. Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.
Kankala RK; Wang SB; Chen AZ
Curr Pharm Des; 2018; 24(45):5354-5366. PubMed ID: 30799783
[TBL] [Abstract][Full Text] [Related]
25. Recent progress of microfluidic technology for pharmaceutical analysis.
Jia X; Yang X; Luo G; Liang Q
J Pharm Biomed Anal; 2022 Feb; 209():114534. PubMed ID: 34929566
[TBL] [Abstract][Full Text] [Related]
26. Reconstituted Human Organ Models as a Translational Tool for Human Organ Response: Definition, Expectations, Cases, and Strategies for Implementation in Drug Discovery and Development.
Tetsuka K; Ohbuchi M; Kawabe T; Goto T; Kiyonaga F; Takama K; Yamazaki S; Fujimori A
Biol Pharm Bull; 2020; 43(3):375-383. PubMed ID: 32115499
[TBL] [Abstract][Full Text] [Related]
27. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
[TBL] [Abstract][Full Text] [Related]
28. Engineering mechanobiology through organoids-on-chip: A strategy to boost therapeutics.
Charelli LE; Ferreira JPD; Naveira-Cotta CP; Balbino TA
J Tissue Eng Regen Med; 2021 Nov; 15(11):883-899. PubMed ID: 34339588
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular human organ-on-a-chip platform for disease modeling, drug development, and personalized therapy.
Khanna A; Oropeza BP; Huang NF
J Biomed Mater Res A; 2024 Apr; 112(4):512-523. PubMed ID: 37668192
[TBL] [Abstract][Full Text] [Related]
30. Imaging microphysiological systems: a review.
Peel S; Jackman M
Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
[TBL] [Abstract][Full Text] [Related]
31. New Endeavors of (Micro)Tissue Engineering: Cells Tissues Organs on-Chip and Communication Thereof.
Ahmed HMMAM; Moreira Teixeira LS
Cells Tissues Organs; 2022; 211(6):721-735. PubMed ID: 34198305
[TBL] [Abstract][Full Text] [Related]
32. Human-Derived Organ-on-a-Chip for Personalized Drug Development.
Jodat YA; Kang MG; Kiaee K; Kim GJ; Martinez AFH; Rosenkranz A; Bae H; Shin SR
Curr Pharm Des; 2018; 24(45):5471-5486. PubMed ID: 30854951
[TBL] [Abstract][Full Text] [Related]
33. Emerging trends in organ-on-a-chip systems for drug screening.
Wang Y; Gao Y; Pan Y; Zhou D; Liu Y; Yin Y; Yang J; Wang Y; Song Y
Acta Pharm Sin B; 2023 Jun; 13(6):2483-2509. PubMed ID: 37425038
[TBL] [Abstract][Full Text] [Related]
34. Organ-on-a-Chip.
Maschmeyer I; Kakava S
Adv Biochem Eng Biotechnol; 2022; 179():311-342. PubMed ID: 32948885
[TBL] [Abstract][Full Text] [Related]
35. Organ Chips and Visualization of Biological Systems.
Tian T; Liu J; Zhu H
Adv Exp Med Biol; 2023; 1199():155-183. PubMed ID: 37460731
[TBL] [Abstract][Full Text] [Related]
36. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
[TBL] [Abstract][Full Text] [Related]
37. Lung-on-a-chip: the future of respiratory disease models and pharmacological studies.
Shrestha J; Razavi Bazaz S; Aboulkheyr Es H; Yaghobian Azari D; Thierry B; Ebrahimi Warkiani M; Ghadiri M
Crit Rev Biotechnol; 2020 Mar; 40(2):213-230. PubMed ID: 31906727
[TBL] [Abstract][Full Text] [Related]
38. From animal testing to
Reyes DR; Esch MB; Ewart L; Nasiri R; Herland A; Sung K; Piergiovanni M; Lucchesi C; Shoemaker JT; Vukasinovic J; Nakae H; Hickman J; Pant K; Taylor A; Heinz N; Ashammakhi N
Lab Chip; 2024 Feb; 24(5):1076-1087. PubMed ID: 38372151
[TBL] [Abstract][Full Text] [Related]
39. Corneal epithelium models for safety assessment in drug development: Present and future directions.
Abdalkader RK; Fujita T
Exp Eye Res; 2023 Dec; 237():109697. PubMed ID: 37890755
[TBL] [Abstract][Full Text] [Related]
40. Microfluidic organ-on-a-chip models of human liver tissue.
Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
